Anti-N3pGlu amyloid beta antibodies and uses thereof
Methods of treating, preventing and / or retarding the progression of cognitive decline, in human subjects having a disease characterized by deposition of A[beta] in the brain including Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy, using anti-N3pGlu A[beta] antibod...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methods of treating, preventing and / or retarding the progression of cognitive decline, in human subjects having a disease characterized by deposition of A[beta] in the brain including Alzheimer's disease, Down's syndrome, and cerebral amyloid angiopathy, using anti-N3pGlu A[beta] antibodies. |
---|---|
Bibliography: | Application Number: TW202211108639 |